drug-discovery

To calculate drug-likeness, you can evaluate compounds using Lipinski's Rule of Five (Ro5), QED, TPSA, and synthetic accessibility metrics. This assists in lead optimization by filtering candidates based on their molecular properties and determining their suitability for further development.

Yes, you can search ChEMBL for bioactive compounds to identify candidates for specific targets. This workflow queries public APIs to retrieve bioactivity data, supporting medicinal chemistry research and open-science drug discovery workflows.

You can check drug-drug interactions and interpret ADMET data by querying the OpenFDA database. This process evaluates safety assessments and clinical pharmacology reviews by retrieving and analyzing public regulatory data.

To run chemoinformatics workflows, you need Python3 and curl installed. The environment executes deterministic Python scripts and shell commands to query public APIs like ChEMBL, PubChem, OpenFDA, and OpenTargets for molecular property analysis.

Yes, this approach applies to lead optimization and clinical pharmacology reviews. It integrates bioactive compound search, drug-likeness calculations, and OpenFDA safety assessments to support these medicinal chemistry tasks.

The best way to evaluate aspirin's Ro5 compliance and ADMET properties is to run an integrated workflow that computes drug-likeness metrics and queries OpenFDA for safety data. This provides a complete profile of the molecule's regulatory and pharmacokinetic behavior.